Melatonin associated with acid inhibition as a strategy for chemoprevention in Barrett's esophagus. pilot study [Melatonina asociada a inhibicion acida como estrategia de quimioprevencion en esofago de Barrett. Estudio piloto].

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 10 Oct 2022

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Melatonin (Primary) ; Omeprazole
Indications Barrett's oesophagus; Oesophageal cancer
Focus Biomarker; Pharmacodynamics; Therapeutic Use

Most Recent Events

12 Sep 2019 Status changed from recruiting to completed.
20 Apr 2012 Status changed from not yet recruiting to recruiting as reported by ISRCTN: Current Controlled Trials.
20 Apr 2012 New source identified and integrated (ISRCTN: Current Controlled Trials; 95230916).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight